These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22315863)

  • 21. Common problems in routine pre-transfusion testing.
    Chandanayingyong D
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):193-5. PubMed ID: 118531
    [No Abstract]   [Full Text] [Related]  

  • 22. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation?
    Hori T; Uemoto S; Takada Y; Oike F; Ogura Y; Ogawa K; Miyagawa-Hayashino A; Yurugi K; Nguyen JH; Hori Y; Chen F; Egawa H
    Surgery; 2010 Jun; 147(6):840-4. PubMed ID: 20096431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-A antibody transfused with non-group-specific platelets. Serological abnormalities.
    Thomas L; Tuscany FL; Wilner GD
    Arch Pathol Lab Med; 1981 Jan; 105(1):52-3. PubMed ID: 6893913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The excellent outcomes of ABO-incompatible kidney transplantation with high titer (>×2048) using anti-CD20 and anti-CD25 antibody without splenectomy: two case reports.
    Koshino K; Okamoto M; Sakai K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Okajima H; Yoshimura N
    Transplant Proc; 2011; 43(6):2379-82. PubMed ID: 21839272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The suitability of hemolyzed specimens for compatibility testing using automated technology.
    Laga A; Cheves T; Maroto S; Coutts M; Sweeney J
    Transfusion; 2008 Aug; 48(8):1713-20. PubMed ID: 18482191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of A
    Saboor M; Zehra A; Hamali HA; Halawani AJ; Mobarki AA; Madkhali AM; Abdullah S
    Int J Gen Med; 2020; 13():787-790. PubMed ID: 33116770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The use of anti-A, anti-B and anti-AB monoclonal antibodies in a blood transfusion center. Preliminary results].
    Micali C; Samà D
    Minerva Med; 1989 Oct; 80(10):1079-81. PubMed ID: 2812464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of emergency cardiac surgery in a patient with alloanti-Ge2.
    Selleng S; Selleng K; Zawadzinski C; Wollert HG; Yürek S; Greinacher A
    Transfus Med; 2009 Feb; 19(1):50-2. PubMed ID: 19302455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Irregular erythrocytic antibodies as an obstacle to transfusion].
    Uhlig R; Endert G; Lammel G
    Z Arztl Fortbild (Jena); 1984; 78(20):849-52. PubMed ID: 6523909
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunological safety in blood transfusion. Current practical rules (author's transl)].
    Rouger P; Salmon C
    Anesth Analg (Paris); 1981; 38(11-12):679-83. PubMed ID: 7114520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Erythrocyte detection with the immunoperoxidase method following 2 failed transfusions in ABO and Rhesus incompatibility--clinical course].
    Heim MU; Pachmann U; Böck M; Geschwändler E; Schleifer A; Eckstein R; Mempel W
    Beitr Infusionsther; 1988; 21():255-8. PubMed ID: 2462987
    [No Abstract]   [Full Text] [Related]  

  • 33. The blood bank "black box" debunked: pretransfusion testing explained.
    Yazer MH
    CMAJ; 2006 Jan; 174(1):29-32. PubMed ID: 16389232
    [No Abstract]   [Full Text] [Related]  

  • 34. Donors' blood group declaration before donation can be used as a tool for electronic crossmatching.
    Arslan O
    Transfus Med; 2005 Dec; 15(6):487-92. PubMed ID: 16359420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets.
    Cooling LL; Downs TA; Butch SH; Davenport RD
    Transfusion; 2008 Oct; 48(10):2106-13. PubMed ID: 18631162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood transfusion and blood bank management in a tropical country.
    David-West AS
    Clin Haematol; 1981 Oct; 10(3):1013-28. PubMed ID: 6796320
    [No Abstract]   [Full Text] [Related]  

  • 37. A series of surveys on assay for anti-A/B antibody by Japanese ABO-incompatible Transplantation Committee.
    Kobayashi T; Saito K
    Xenotransplantation; 2006 Mar; 13(2):136-40. PubMed ID: 16623808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Problems associated with compatibility testing for patients with autoimmune hemolytic anemia.
    Garratty G
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():76-9. PubMed ID: 7886613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies.
    Kumlien G; Ullström L; Losvall A; Persson LG; Tydén G
    Transfusion; 2006 Sep; 46(9):1568-75. PubMed ID: 16965585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ABO blood groups and platelet transfusion].
    Eckstein R; Zeiler T; Zingsem J; Heuft HG; Musch R; Weisbach V
    Beitr Infusionsther; 1990; 26():157-9. PubMed ID: 1703819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.